Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer E O’Brien , Nely Wigler , Moshe Inbar +11 more 2004 Annals of Oncology 1672 citations